Author:
Mamounas Eleftherios P.,Geyer Charles E.,Swain Sandra M.
Reference63 articles.
1. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group;Lancet,1998
2. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer;Henderson;J Clin Oncol,2003
3. Paclitaxel (T) following doxorubicin/cyclophosphamide (AC) as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28;Mamounas;Proc Am Soc Clin Oncol,2003
4. Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial;Blackstein;Oncology,2002
5. Phase III trial comparing TAC (docetaxel, doxorubincin, cyclophosphamide) with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients: interim analysis of the BCIRG 0001 study;Nabholtz;Proc Am Soc Clin Oncol,2002
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献